OTCMKTS:VEGPF Vectura Group (VEGPF) Stock Price, News & Analysis → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free VEGPF Stock Alerts $1.77 0.00 (0.00%) (As of 11/1/2021) Add Compare Share Share Today's Range$1.77▼$1.7750-Day Range$1.77▼$1.7752-Week Range$1.64▼$2.74VolumeN/AAverage Volume2,185 shsMarket Capitalization$1.07 billionP/E Ratio6.81Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vectura Group alerts: Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About Vectura Group Stock (OTCMKTS:VEGPF)Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.Read More VEGPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VEGPF Stock News HeadlinesJanuary 16, 2023 | thestreet.comEuropean Stocks See Mixed Session as U.K.'s FTSE LeadsJanuary 15, 2023 | finance.yahoo.comVECTURA GROUP LS -,000271 (V4TA.BE)May 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.January 9, 2023 | finance.yahoo.comVectura Group PLC (V4TA.BE)July 18, 2022 | benzinga.comVectura Group (OTC:VEGPF), Short Interest ReportAugust 27, 2021 | uk.finance.yahoo.comCarlyle stays in race for VecturaAugust 27, 2021 | finance.yahoo.comForm 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210826August 20, 2021 | uk.finance.yahoo.comPhilip Morris chief attacks critics as Vectura bid tests investorsMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.August 13, 2021 | uk.finance.yahoo.comMarkets: FTSE inches to new post-pandemic high as Vectura takeover draws closerAugust 10, 2021 | uk.finance.yahoo.comVectura auction called off after Carlyle declines to beat Philip Morris bidAugust 9, 2021 | finance.yahoo.comUPDATE 1-Vectura takeover battle could slip into auction - UK regulatorAugust 9, 2021 | ca.finance.yahoo.comPhilip Morris, Carlyle could fight it out for UK's Vectura in auction ringSee More Headlines Receive VEGPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:VEGPF CUSIPN/A CIKN/A Webwww.vectura.com Phone441249667700FaxN/AEmployees502Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio6.81 Forward P/E Ratio19.67 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$244.76 million Price / Sales4.37 Cash Flow$0.28 per share Price / Cash Flow6.33 Book Value$1.16 per share Price / Book1.53Miscellaneous Outstanding Shares604,260,000Free FloatN/AMarket Cap$1.07 billion OptionableNot Optionable Beta0.37 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesWill DownieChief Executive Officer & Executive DirectorAnthony FitzpatrickExecutive Vice President-OperationsPaul Andrew FryChief Financial Officer & Executive DirectorGonzalo de MiquelChief Medical Officer & Executive VP-DevelopmentRoger HeermanExecutive VP-Commercial & Business DevelopmentKey CompetitorsCannTrustOTCMKTS:CNTTFAbCellera BiologicsNASDAQ:ABCLArcutis BiotherapeuticsNASDAQ:ARQTLiquidiaNASDAQ:LQDAProthenaNASDAQ:PRTAView All Competitors VEGPF Stock Analysis - Frequently Asked Questions How have VEGPF shares performed in 2024? Vectura Group's stock was trading at $1.77 at the beginning of 2024. Since then, VEGPF shares have increased by 0.0% and is now trading at $1.77. View the best growth stocks for 2024 here. How do I buy shares of Vectura Group? Shares of VEGPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VEGPF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vectura Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
